-- 
Merrion Pharma Says Novo Nordisk Won’t Be Exercising Option

-- B y   D a r a   D o y l e
-- 
2011-10-20T15:21:43Z

-- http://www.bloomberg.com/news/2011-10-20/merrion-pharma-says-novo-nordisk-won-t-be-exercising-option.html
  Merrion Pharmaceuticals Plc 
said it has been informed by its partner, Novo Nordisk A/S, that
Novo will not be exercising an option described in the agreement
announced by Merrion on Dec. 22. “Merrion will not meet its
revenue targets for 2011,” it said.    
Link to Statement:{NSN LTDEEY3HBS3K <GO>}  To contact the editor responsible for this story:
Dara Doyle at 
 ddoyle1@bloomberg.net  